Medical device maker Abbott Laboratories is nearing a potential takeover of cancer test maker Exact Sciences Corp, Bloomberg ...

All adverse outcomes were of mild or moderate severity, and no significant trends were observed on the basis of LVEF status. The most common adverse events were hypotension (33%-36.4%), arrhythmia ...

Scientists have created swallowable microsphere “pills” packed with engineered bacteria that can detect signs of gut disease, ...

Chinese researchers have developed a new sensor made of tiny microspheres packed with blood-sensing bacteria that detect ...

As screening guidelines evolve and GI care increasingly shifts to outpatient settings, ASCs are seeing significant growth in colonoscopy volume. Here are ten developments shaping that trend: ...

Bloomberg reports today that Abbott (NYSE: ABT) is close to a deal to acquire diagnostics developer Exact Sciences (Nasdaq:EXAS).

Move over, colonoscopies—researchers report in ACS Sensors that they've developed a sensor made of tiny microspheres packed ...

Move over, colonoscopies - researchers report in ACS Sensors that they've developed a sensor made of tiny microspheres packed with blood-sensing bacteria that detect markers of gastrointestinal ...

Gastrointestinal procedures continue to dominate the ASC landscape in 2025, driven by increased screening demand, younger-onset colorectal cancer and ongoing migration of cases out of hospitals. All ...

Your primary care provider is more than just your annual stop for routine checkups. They're also the central hub for coordinating your health care, from specialist visits to follow-up testing ...

On 'Live with Kelly and Mark,' Mark Consuelos admitted that he should have already gotten screened for colon cancer.

Scientists have discovered that collecting stool samples at home is as life-saving as invasive colonoscopy procedures.